@viq@novid@covid19 The long-term impact of COVID is just so terribly sad. And I feel despondent with the widespread cognitive dissonance. So many people have fooled themselves into thinking we’re back to normal. Nothing is normal anymore.
“we have demonstrated that there were no statistically significant differences in the retinal microvasculature of patients with #postCOVID19 syndrome compared to healthy cohorts. Furthermore, no significant structural differences were observed in the macular retinal nerve fibre layer (RNFL) & ganglion cell layer (GCL) of the study participants”
“Our data suggest that millions of Americans presenting with PVS resembling NeuroPASC were indeed exposed to #SARSCoV2 at the beginning of the pandemic, and they deserve the same access to care and inclusion in research studies as patients with NP with confirmed #COVID19 diagnosis”
“Even after more than one year, individuals with SARS-CoV-2 infection showed an increased risk of various health complaints, functional limitations, & worse subjective well-being, pointing toward profound health consequences of #SARSCoV2 infection relevant for public health”
Includes patient commentary:
“As a doctor myself, I am all too aware of poorly understood clinical presentations. I now carefully frame how I tell a patient their test results are normal. Instead I tell them that the results don’t explain their symptoms. This avoids a misunderstanding that I might think their symptoms are imagined or due to anxiety”
“We performed fungiform papillae biopsies on 16 patients who reported taste disturbance lasting more than 6 weeks after […] infection.” “In all patients, we found evidence of #SARSCoV2, accompanying immune response and misshapen or absent taste buds with loss of intergemmal neurite fibers”
British Medical Journal: How can I support my colleague returning to work with #LongCovid
“Remember that no two people with Long Covid will be the same in terms of their challenges, so the approach to returning to work needs to be bespoke and may look different to others.”
BMJ Careers by Abi Rimmer
Review article. "The sustained activation of the KP [kynurenine pathway], associated with cognitive impairments & chronic fatigue, underscores the potential of KP as a therapeutic target & as a possible biomarker for #longCOVID in future studies”
